Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 19, 2025, ESSA Pharma (EPIX) has a market cap of $79.456 million USD. According to our data, ESSA Pharma is ranked No.7753 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 19, 2025 | $79.46 M |
-0.00%
|
| Dec 31, 2024 | $79.46 M |
-72.88%
|
| Dec 29, 2023 | $0.29 B |
161.90%
|
| Dec 30, 2022 | $0.11 B |
-82.25%
|
| Dec 31, 2021 | $0.63 B |
19.03%
|
| Dec 31, 2020 | $0.53 B |
116.91%
|
| Dec 31, 2019 | $0.24 B |
161.90%
|
| Dec 31, 2018 | $93.22 M |
-52.05%
|
| Dec 29, 2017 | $0.19 B |
-90.00%
|
| Dec 30, 2016 | $1.94 B |
-48.47%
|
| Dec 31, 2015 | $3.77 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Arvinas
ARVN
|
$0.59 B |
0.000 M
|
USA
|
 AstraZeneca
AZN
|
$210.29 B |
0.735 B
|
UK
|
 Bristol-Myers Squibb
BMY
|
$100.17 B |
-0.004 M
|
USA
|
 Eli Lilly
LLY
|
$754.27 B |
0.008 M
|
USA
|
 Gilead Sciences
GILD
|
$130.32 B |
-0.001 M
|
USA
|
 Johnson & Johnson
JNJ
|
$379.48 B |
-0.003 M
|
USA
|
 Merck
MRK
|
$196.28 B |
0.008 M
|
USA
|
 Pfizer
PFE
|
$125.57 B |
0.001 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$61.57 B |
1.023 B
|
USA
|
 Sanofi
SNY
|
$124.64 B |
0.327 B
|
France
|
 Vertex Pharmaceuticals
VRTX
|
$125.74 B |
-0.003 M
|
USA
|
 Novartis
NVS
|
$219.89 B |
0.932 B
|
Switzerland
|
| Market Cap | = | EPIX Stock Price | * | EPIX Shares Outstanding |
| = | $1.79 | * | 44.39 M | |
| = | $79.46 M |